Executive summary of the KDIGO 2024 Clinical Practice Guideline for the evaluation and management of chronic kidney disease: Known knowns and known unknowns

Levin, Adeera; Ahmed, Sofia B; Carrero, Juan Jesus; Foster, Bethany; Francis, Anna; Hall, Rasheeda K; Herrington, Will G; Hill, Guy; Inker, Lesley A; Kazancıoğlu, Rümeyza; Lamb, Edmund; Lin, Peter; Madero, Magdalena; McIntyre, Natasha; Morrow, Kelly; Roberts, Glenda; Sabanayagam, Dharshana; Schaeffner, Elke; Shlipak, Michael; Shroff, Rukshana; Tangri, Navdeep; Thanachayanont, Teerawat; Ulasi, Ifeoma; Wong, Germaine; Yang, Chih-Wei; Zhang, Luxia; Robinson, Karen A; Wilson, Lisa; Wilson, Renee F; Kasiske, Bertram L; Cheung, Michael; Earley, Amy; Stevens, Paul E.

Kidney int; 105 (4), 2024

Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD) updates the KDIGO 2012 guideline and has been developed with patient partners, clinicians, and researchers around the world, using robust methodology. This update, based on a su...

Insuffisance rénale chronique/traitement médicamenteux, Insuffisance rénale chronique/diagnostic, Débit de filtration glomérulaire, Créatinine/analyse, Sérumalbumine/analyse, Régulation de la glycémie, Inhibiteurs de l'enzyme de conversion de l'angiotensine/usage thérapeutique, Inhibiteurs du cotransporteur sodium-glucose de type 2/usage thérapeutique, Anémie/thérapie

Texte intégral

Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence

Rossing, Peter; Caramori, Luiza M; Chan, Juliana C. N; Earley, Amy; de Boer, Ian H.

Kidney int; 102 (5), 2022

The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) represents a focused update of the KDIGO 2020 guideline on the topic. The guideline targets a broad audience of clinicians treating people with diabetes and CKD. ...

Insuffisance rénale chronique/traitement médicamenteux, Diabète de type 2/prévention et contrôle, Gestion de soi, Régulation de la glycémie, Inhibiteurs de l'enzyme de conversion de l'angiotensine/usage thérapeutique, Antagonistes des récepteurs aux angiotensines/usage thérapeutique, Inhibiteurs du cotransporteur sodium-glucose de type 2/usage thérapeutique

Texte intégral

Guías de práctica clínicas prevención secundaria de la enfermedad renal crónica

Chile. Ministerio de Salud. Gobierno de Chile.

Entregar recomendaciones para apoyar a los equipos de salud en la toma de decisiones respecto al diagnóstico, tratamiento y derivación de las personas con ERC....

Insuffisance rénale chronique/prévention et contrôle, Insuffisance rénale chronique/diagnostic, Insuffisance rénale chronique/traitement médicamenteux, Débit de filtration glomérulaire, Protéinurie/urine, Albuminurie/urine, Antiviraux/usage thérapeutique, Antibactériens/usage thérapeutique, Hypolipémiants/usage thérapeutique, Insuline/usage thérapeutique

Texte intégral

Chronic kidney disease in adults: assessment and management

England. National Institute for Health and Care Excellence.

This guideline covers the care and treatment of people with, or at risk of developing, chronic kidney disease. It aims to prevent or delay the progression of chronic kidney disease, reduce or prevent the development of complications, and reduce the risk of cardiovascular disease....

Insuffisance rénale chronique/diagnostic, Insuffisance rénale chronique/prévention et contrôle, Insuffisance rénale chronique/traitement médicamenteux, Antihypertenseurs/usage thérapeutique, Système rénine-angiotensine, Antiagrégants plaquettaires/usage thérapeutique, Anticoagulants/usage thérapeutique

Texte intégral

Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: a clinical practice guideline from the American College of Physicians

Qaseem, A; Hopkins, RH Jr; Sweet, D. E; Starkey, M; Shekelle, P.

Ann. intern. med; 159 (12), 2013

DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the screening, monitoring, and treatment of adults with stage 1 to 3 chronic kidney disease. METHODS: This guideline is based on a systematic evidence review eval...

Insuffisance rénale chronique/diagnostic, Insuffisance rénale chronique/traitement médicamenteux, Évolution de la maladie, Triage, Antagonistes des récepteurs aux angiotensines/usage thérapeutique, Inhibiteurs de l'enzyme de conversion de l'angiotensine/usage thérapeutique, Antihypertenseurs/usage thérapeutique, Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase/usage thérapeutique, Hypolipémiants/usage thérapeutique, Gemfibrozil/usage thérapeutique, Maladies asymptomatiques, Association de médicaments, Approche GRADE

Texte intégral